Paul Hudson is 'open-minded' to M&A as he plots Sanofi's transformation: #JPM24
SAN FRANCISCO — Sanofi CEO Paul Hudson reiterated his ambitions for the “new” Sanofi, including business development plans ahead of what some experts predict will be a busy year for M&A in the biopharma sector.
Hudson said Tuesday during an investor presentation at the JP Morgan Healthcare Conference that he’s open-minded about M&A, though he noted it will take “game-changing science” for the company to act.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.